Botanical species · safety record

Clinopodium menthifolium

The EFSA Compendium of Botanicals holds 18 constituent measurements for Clinopodium menthifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Clinopodium menthifolium (Host) Stace

18Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Calamintha menthifolia Host.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(+)-pulegone	Aerial part of plants	Essential oil	≤ 0.2 Percent	GC-MS	Resolve DOI
(+)-pulegone	Aerial part of plants	Essential oil	≤ 20.1 Percent	GC-MS	Resolve DOI
(+)-pulegone	Aerial part of plants	Essential oil	6.9 Percent	GC-MS	Resolve DOI
1,8-cineole	Aerial part of plants	Essential oil	≤ 0.2 Percent	GC-MS	Resolve DOI
Cis-isopulegone	Aerial part of plants	Essential oil	75.2 Percent	GC-MS	Resolve DOI
Cis-piperitone epoxide	Aerial part of plants	Essential oil	≤ 88.2 Percent	GC-MS	Resolve DOI
Isopiperitenone	Aerial part of plants	Essential oil	≤ 0.6 Percent	GC-MS	Resolve DOI
Isopiperitenone	Aerial part of plants	Essential oil	≥ 0.3 Percent	GC-MS	Resolve DOI
P-menth-1-en-3-one	Aerial part of plants	Essential oil	≤ 10.4 Percent	GC-MS	Resolve DOI
Piperitenone oxide	Aerial part of plants	Essential oil	≤ 2.3 Percent	GC-MS	Resolve DOI
Piperitenone oxide	Aerial part of plants	Essential oil	≤ 2.3 Percent	GC-MS	Resolve DOI
Piperitenone oxide	Aerial part of plants	Essential oil	≥ 0.2 Percent	GC-MS	Resolve DOI
Piperitone oxide	Aerial part of plants	Essential oil	≤ 67.6 Percent	GC-MS	Resolve DOI
Piperitone oxide	Aerial part of plants	Essential oil	≥ 62.9 Percent	GC-MS	Resolve DOI
Trans-isopulegone	Aerial part of plants	Essential oil	4.5 Percent	GC-MS	Resolve DOI
Trans-piperitone oxide	Aerial part of plants	Essential oil	≤ 2.4 Percent	GC-MS	Resolve DOI
D,l-isomenthone	Live plants	Essential oil	≤ 43.3 Percent	GC-MS	No resolvable identifier
D,l-isomenthone	Live plants	Essential oil	≥ 36.8 Percent	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Karousou, R., Hanlidou, E., Lazari, D. Essential-oil diversity of three calamintha species from greece. Chemistry and Biodiversity, 2012, vol. 9, no. 7, p. 1364-1372. DOI
HANLIDOU, E., KOKKINI, S., BOSABALIDIS, AM., BESSIERE, JM. GLANDULAR TRICHOMES AND ESSENTIAL OIL CONSTITUENTS OF CALAMINTHA-MENTHIFOLIA (LAMIACEAE). PLANT SYSTEMATICS AND EVOLUTION, 1991, vol. 177, no. 1-2, p. 1726. DOI
Castilho, Paula., Liu, Kai., Rodrigues, Ana Isabel., Feio, Sonia., Tomi, Felix., Casanova, Joseph. Composition and antimicrobial activity of the essential oil of Clinopodium ascendens (Jordan) Sampaio from Madeira . Flavour and fragrance journal, 2007, vol. 22, no. 2, p. 139-144. DOI
Hidalgo, PJ., Ubera, JL., Santos, JA., LaFont, F., Castellanos, C., Palomino, A., Roman, M. Essential oils in Calamintha sylvatica Bromf. ssp ascendens (Jordan) P.W. Ball: Wild and cultivated productions and antifungal activity . Journal of essential oil research, 2002, vol. 14, no. 1, p. 68-71.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature